| Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. | |
| | |
MedLine Citation:
|
PMID: 15742328 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Gastrointestinal (GI) carcinoids, considered to be endocrine neoplasms with relatively low levels of malignancy, have never been examined in large, statistically reliable series to determine their true aggressive behavior in the early stage of both minute (</= 5 mm) or small (5.1-10.0 mm) tumors at a depth of invasion restricted to the mucosa and submucosa (sm carcinoids). METHODS: Of a total number of 1914 cases of GI sm carcinoids selected from the Niigata Registry, 1614 with the tumor size recorded on a millimeter scale were categorized in 5-mm size intervals and rates of metastases were calculated for those in each size category. Of statistical significance was confirmation that the rectum (n = 849), the stomach (n = 449), the duodenum (n = 349), and the jejunoileum (n = 149) were among the principal growth sites. The Kaplan-Meier method was used to calculate 5-year-survival rates (5YSRs) and a comparative study was undertaken. RESULTS: GI sm carcinoids exhibited a metastasis rate of 16.4% (264 of 1614) as a whole and minute carcinoids (</= 5 mm) revealed an unexpectedly high metastasis rate of 6.0% (24 of 399) on average, which ranged from 3.7% (8 of 216) in the rectum to 17.2% (5 of 29) in the jejunoileum. Small carcinoids measuring 5.1-10 mm also showed a high metastasis rate of 13.3% (90 of 675) on average, ranging from 9.6% (12 of 125) in the stomach to 41.2% (14 of 34) in the jejunoileum. The combined average metastasis rate for both minute and small carcinoids combined (</= 10 mm) was as high as 10.6% (114 of 1074). The comparative study confirmed that, in both the stomach and the rectum, the metastasis rate of sm carcinoids was significantly higher than that for ordinary sm carcinomas in tumors > 10 mm. Although most patients (92.8%; 1777 of 1914) underwent an endoscopy and/or a wider resection of the lesions, nonresectable metastases were found in 22 patients (1.1%). Of these, 16 had undergone a laparotomy and 6 had not received surgery. Among 1001 patients with GI sm carcinoids, the 5YSRs after curative resection ranged from 98.3% in the rectum to 89.6% in the stomach (P < 0.05), representing an average of 96.7% for the entire series. CONCLUSIONS: Unexpectedly high aggressiveness in metastasis rates in both rectal and gastric sm carcinoids > 10 mm exhibiting values significantly higher than those of sm carcinomas were found in 1914 patients suffering from GI sm carcinoids. However, in sm carcinoids at either the minute or small tumor stage (tumors </= 10 mm), the metastasis rates were comparable to those of sm carcinomas. It should be emphasized that the 5YSRs for patients with GI sm carcinoids may be comparable to those with sm carcinomas in certain cases. These points should be taken into consideration when treating patients with GI carcinoids, particularly in the early stage, and even with the depth of invasion confined to the submucosa. |
| | |
Authors:
|
Jun Soga |
Related Documents
:
|
18613448 - Efficacy of prophylactic extended lymphadenectomy with gastrectomy for patients with no... 7871368 - Radical surgery (r2 resection) for gastric cancer. a multivariate analysis. 15864718 - Long-term outcome of s-1 and cisplatin combination therapy in patients with advanced or... 20941968 - Palliative gastrectomy in patients with stage iv gastric cancer--our recent experience. 11531298 - Nodal distribution and its significance in figo stage iiic endometrial cancer. 8942548 - Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophag... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Cancer Volume: 103 ISSN: 0008-543X ISO Abbreviation: Cancer Publication Date: 2005 Apr |
Date Detail:
|
Created Date: 2005-04-13 Completed Date: 2005-05-26 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0374236 Medline TA: Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 1587-95 Citation Subset: AIM; IM |
Copyright Information:
|
(c) 2005 American Cancer Society. |
Affiliation:
|
Niigata Seiryo University, Niigata, Japan. soga@n-seiryo.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Carcinoid Tumor / mortality, pathology* Child Child, Preschool Endocrine Glands / pathology* Female Gastrointestinal Neoplasms / mortality, pathology* Humans Incidence Male Middle Aged Neoplasm Metastasis / pathology Prognosis Registries Survival Rate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Improved proteome coverage by using high efficiency cysteinyl peptide enrichment: the human mammary ...
Next Document: Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration ...